Tenecteplase versus alteplase for acute ischemic stroke: a systematic review and meta-analysis of randomized and non-randomized studies
Objective Alteplase is the current standard of care for acute ischemic stroke. Tenecteplase is
a newer fibrinolytic agent with preferable administration and lower costs; however, its …
a newer fibrinolytic agent with preferable administration and lower costs; however, its …
Evaluation of Door-to-Needle Times Between Alteplase and Tenecteplase for Acute Ischemic Stroke at Two Academic Medical Centers
NJ Monkemeyer, KK Marino… - Annals of …, 2024 - journals.sagepub.com
Background: Off-label tenecteplase use for acute ischemic stroke (AIS) has increased due to
ease of administration and comparable efficacy and safety to alteplase. Objective: This study …
ease of administration and comparable efficacy and safety to alteplase. Objective: This study …
[HTML][HTML] A Comparative Study of Hemorrhagic Conversion Patterns After Stroke Thrombolysis With Alteplase Versus Tenecteplase
M Ezzeldin, C Hill, A Kerro, E Percenti, A Delora… - Cureus, 2023 - ncbi.nlm.nih.gov
Background and purpose: Tenecteplase is the thrombolytic drug of choice for acute ischemic
stroke (AIS) as it has unique pharmacologic properties, along with results demonstrating its …
stroke (AIS) as it has unique pharmacologic properties, along with results demonstrating its …
[HTML][HTML] Angioedema Secondary to Tenecteplase Use in a Patient with Acute Ischemic Stroke: A Case Report
B Newman, M Poremba… - Clinical Practice and …, 2024 - pmc.ncbi.nlm.nih.gov
Introduction Angioedema, a swelling of the subcutaneous or submucosal layers of the skin
or gastrointestinal tract, is a potential complication to thrombolytic therapy in the treatment of …
or gastrointestinal tract, is a potential complication to thrombolytic therapy in the treatment of …